Whalegun
Home

Neurocrine Biosciences NBIX paid Ricchetti $50K for lobbying in Q1 2023 · Medicare, Pharmacy and 1 more issue

Trade details

Type
Lobbying report
Amount
$50,000
Quarter
Q1 2023
Stock
Neurocrine Biosciences NBIX
Client
Neurocrine Biosciences
Reported
23/04/18

Up 0.0% from last quarter

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/03/01~23/04/30

Neurocrine Biosciences's other lobbying reports